These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32309939)

  • 1. Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery.
    Yan XC; Sanders JM; Gao YD; Tudor M; Haidle AM; Klein DJ; Converso A; Lesburg CA; Zang Y; Wood HB
    J Chem Inf Model; 2020 Sep; 60(9):4144-4152. PubMed ID: 32309939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification.
    Ballester PJ; Mangold M; Howard NI; Robinson RL; Abell C; Blumberger J; Mitchell JB
    J R Soc Interface; 2012 Dec; 9(77):3196-207. PubMed ID: 22933186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The holistic integration of virtual screening in drug discovery.
    Tanrikulu Y; Krüger B; Proschak E
    Drug Discov Today; 2013 Apr; 18(7-8):358-64. PubMed ID: 23340112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity & tractability revisited in collaborative small molecule phenotypic screening library design.
    Lahue BR; Glick M; Tudor M; Johnson SA; Diratsouian J; Wildey MJ; Burton M; Mazzola R; Wassermann AM
    Bioorg Med Chem; 2020 Jan; 28(1):115192. PubMed ID: 31837897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-aided drug discovery research at a global contract research organization.
    Kitchen DB
    J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased Complement Diversity Selection for Effective Exploration of Chemical Space in Hit-Finding Campaigns.
    Jansen JM; De Pascale G; Fong S; Lindvall M; Moser HE; Pfister K; Warne B; Wartchow C
    J Chem Inf Model; 2019 May; 59(5):1709-1714. PubMed ID: 30943027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hit-to-Lead: Hit Validation and Assessment.
    Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
    Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multimodal Data Analysis Approach for Targeted Drug Discovery Involving Topological Data Analysis (TDA).
    Alagappan M; Jiang D; Denko N; Koong AC
    Adv Exp Med Biol; 2016; 899():253-68. PubMed ID: 27325272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Testing of Druglike Screening Libraries.
    Wang J; Ge Y; Xie XQ
    J Chem Inf Model; 2019 Jan; 59(1):53-65. PubMed ID: 30563329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of protein binding pocket properties with hits' chemistries used in generation of ultra-large virtual libraries.
    Song RX; Nicklaus MC; Tarasova NI
    J Comput Aided Mol Des; 2024 May; 38(1):22. PubMed ID: 38753096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns.
    Rothenaigner I; Hadian K
    SLAS Discov; 2021 Aug; 26(7):851-854. PubMed ID: 33882754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient hit-finding approaches for histone methyltransferases: the key parameters.
    Ahrens T; Bergner A; Sheppard D; Hafenbradl D
    J Biomol Screen; 2012 Jan; 17(1):85-98. PubMed ID: 21990582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis.
    Zhu T; Cao S; Su PC; Patel R; Shah D; Chokshi HB; Szukala R; Johnson ME; Hevener KE
    J Med Chem; 2013 Sep; 56(17):6560-72. PubMed ID: 23688234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of virtual and high throughput screening in lead discovery settings.
    Polgár T; Keseru GM
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):889-97. PubMed ID: 21843143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.